Hastings Advances Thai Hydromet Plant Toward Q4 2026 MREC Production with Strong Cash Flow Outlook

Near-Term Production Pathway Established for Kabin Buri Plant

Hastings Technology Metals Ltd (ASX:HAS) is gearing up to deliver its first Mixed Rare Earth Chloride (MREC) flakes from the Kabin Buri Hydromet Plant in Thailand by the fourth quarter of 2026. The plant’s commissioning phase is scheduled to begin in June, with initial production capacity set at 6,000 tonnes per annum (tpa) of MREC from 5,000 tpa of African Monazite Concentrate feedstock. This milestone marks a significant step in Hastings’ strategy to generate near-term cash flow ahead of its flagship Yangibana Rare Earths project ramping up in Western Australia.

The company’s recent acquisition of a 49% stake in the Hydromet Plant, progressing through due diligence, complements its upstream mining assets and positions Hastings as a vertically integrated rare earths producer. This development follows Hastings’ earlier securing of African monazite supply via a Framework Offtake Agreement with Enuo Holdings Pte Ltd, which underpins the plant’s feedstock requirements and supports the operational timeline.

Proprietary Seven-Stage Hydrometallurgical Process

The plant utilises a proven seven-stage caustic-leach hydrometallurgical flowsheet designed to convert monazite concentrate with ≥54% total rare earth oxides (TREO) into premium-grade MREC flakes. Key process stages include grinding, caustic cracking, acid dissolution, and a dedicated purification step that removes impurities such as iron and thorium, critical for meeting the specifications demanded by high-tech downstream customers in electric vehicles, wind turbines, and advanced electronics.

This chloride-based product holds a sustained market price premium over traditional carbonate intermediates, supported by the Shanghai Metals Market (SMM) index which indicates a ~27% price advantage for rare earth chlorides. Hastings’ process also recycles reagents such as sodium hydroxide, enhancing operational efficiency and cost control.

Thailand’s Eastern Economic Corridor Offers Structural Cost Advantages

Locating the Hydromet Plant in Thailand’s Eastern Economic Corridor (EEC) delivers a significant competitive edge through materially lower operating costs. Labour costs for plant operators are a fraction of Western Australian equivalents, industrial electricity tariffs are 30–50% cheaper than remote Australian mine sites, and key reagents like hydrochloric acid and caustic soda are sourced at deep discounts from local petrochemical clusters.

These factors combine to reduce unit operating expenses and support the plant’s projected pretax profits of US$21.6 million in Year 1 (49% share US$10.6 million), scaling to US$43.8 million in Year 2 post a planned capacity expansion to 12,000 tpa MREC output. The expansion, estimated to cost US$3 million, is expected to be funded from operating cash flow generated by Phase 1.

Strategic Integration with Yangibana and Growth Ambitions

Looking beyond initial production, Hastings plans to integrate its upstream Yangibana Joint Venture Project with the Hydromet Plant, potentially shipping Yangibana concentrate to Thailand to boost MREC output and add value. This approach aligns with the company’s ambition to become a fully integrated mine-to-market rare earths supplier and is being pursued in collaboration with joint venture partner Wyloo.

While Phase 2 expansion and further scale-up to 36,000 tpa MREC production remain aspirational and contingent on technical, regulatory, and commercial milestones, the modular plant design allows Hastings to align growth with evolving market demand and feedstock availability.

This update builds on Hastings’ earlier progress securing African monazite supply, which was critical to underpinning the commissioning timeline and feedstock certainty for the Hydromet Plant’s launch later this year.

Uncertainty Around Offtake and Market Conditions

Despite the promising outlook, Hastings has yet to finalise binding offtake agreements for the MREC product, with negotiations ongoing among tier-1 global partners. Financial modelling relies on current market benchmarks such as the SMM Rare Earth Concentrate Index, but actual pricing and volumes remain subject to market fluctuations and contract finalisation.

Investors should also note that the financial projections are unaudited management estimates, and risks remain around feedstock supply continuity, regulatory approvals for expansion, and capital availability. The company cautions that these forward-looking statements may not eventuate as planned.